Type 2 diabetes and heart failure: insights from the global DISCOVER study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Type 2 diabetes and heart failure: insights from the global DISCOVER study

Published:2021-02-11 Issue:2 Volume:8 Page:1711-1716
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Arnold Suzanne V.¹²,Khunti Kamlesh³,Bonnet Fabrice⁴,Charbonnel Bernard⁵,Chen Hungta⁶,Cid‐Ruzafa Javier⁷,Cooper Andrew⁸,Fenici Peter⁸,Gomes Marilia B.⁹,Hammar Niklas¹⁰¹¹,Ji Linong¹²,Luporini‐Saraiva Gabriela⁶,Medina Jesús¹³,Nicolucci Antonio¹⁴,Ramirez Larisa¹⁵,Shestakova Marina V.¹⁶,Shimomura Iichiro¹⁷,Surmont Filip⁸,Tang Fengming¹,Vora Jiten¹⁸,Watada Hirotaka¹⁹,Kosiborod Mikhail¹²,

Affiliation:

1. Saint Luke's Mid America Heart Institute 4401 Wornall Rd Kansas City MO 64111 USA

2. University of Missouri Kansas City MO USA

3. University of Leicester Leicester UK

4. Rennes University Hospital Rennes France

5. University of Nantes Nantes France

6. AstraZeneca Gaithersburg MD USA

7. Evidera Barcelona Spain

8. AstraZeneca Cambridge UK

9. Rio de Janeiro State University Rio de Janeiro Brazil

10. AstraZeneca Gothenburg Mölndal Sweden

11. Institute of Environmental Medicine Karolinska Institute Stockholm Sweden

12. Peking University People's Hospital Beijing China

13. AstraZeneca Madrid Spain

14. Center for Outcomes Research and Clinical Epidemiology Pescara Italy

15. AstraZeneca Luton UK

16. Endocrinology Research Centre Diabetes Institute Moscow Russian Federation

17. Graduate School of Medicine Osaka University Osaka Japan

18. Royal Liverpool University Hospital Liverpool UK

19. Graduate School of Medicine Juntendo University Tokyo Japan

Funder

AstraZeneca

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13235

Reference14 articles.

1. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update

2. Diabetic Cardiomyopathy: A unique entity or a complication of coronary artery disease?

3. Patterns of glucose-lowering medication use in patients with type 2 diabetes and heart failure. Insights from the Diabetes Collaborative Registry (DCR)

4. Risk Factors for Adverse Outcomes by Left Ventricular Ejection Fraction in a Contemporary Heart Failure Population

5. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of glycaemic risk factors and diabetes duration with risk of heart failure in people with type 2 diabetes: A systematic review and meta‐analysis;Diabetes, Obesity and Metabolism;2024-09-13

2. The latest emerging drugs for the treatment of diabetic cardiomyopathy;Expert Opinion on Pharmacotherapy;2024-04-12

3. Sustained SREBP-1 Activation Mediates Cardiac Lipotoxicity to Statins Therapy in Diabetic Mice;2023-12-13

4. Mirror-like tongue is an important predictor of acute heart failure: a cohort study of acute heart failure in Chinese patients;J TRADIT CHIN MED;2023

5. Distinct effects of type 2 diabetes and obesity on cardiopulmonary performance;Diabetes, Obesity and Metabolism;2023-10-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3